Everyone expressing an interest in taking part in the large phase 3 ASPro-PD ambroxol trial will be genetically screened, via PD Frontline, as part of the trial selection criteria. PD Frontline are currently prioritising people under the age of 75 who have been diagnosed with Parkinson’s within the last six years.

Ambroxol and Parkinson’s – find out more here

Registration of interest form:

We also ask you to complete the form below to register your interest with us. This will help you stay up-to-date with Cure Parkinson’s research and fundraising news and direct you on to PD Frontline.

Update as of June 2024: The study team at UCL continue to make significant progress in the setting up of the ASPro-PD trial. They now have 15 potential research centres signed up for the project, ahead of their original goal of 10, across England, Scotland and Wales. The team are currently finalising the required paperwork in preparation for recruitment to begin, including the necessary ethical approvals. Once this is all in place and recruitment has begun, all communication will be provided directly by the ASPro-PD trial team. In our ongoing commitment to keeping you informed, our next update will be in the Autumn unless we have additional news to share before then.

If you have not already done so, please register your interest using the form below. Please also note that PD Frontline will be prioritising people under the age of 75 who have been diagnosed with Parkinson’s in the last six years for genetic screening. If you have any specific questions or concerns, please contact our Recruitment and Retention Officer, Anaya.

Email Anaya